Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 2438-72-4 Chemical Structure| 2438-72-4

Structure of Bufexamac
CAS No.: 2438-72-4

Chemical Structure| 2438-72-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Bufexamac is a COX inhibitor used as an anti-inflammatory agent.

Synonyms: Bufexamic acid

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Bufexamac

CAS No. :2438-72-4
Formula : C12H17NO3
M.W : 223.27
SMILES Code : O=C(NO)CC1=CC=C(OCCCC)C=C1
Synonyms :
Bufexamic acid
English Name :2-(4-Butoxyphenyl)-N-hydroxyacetamide
MDL No. :MFCD00078936
InChI Key :MXJWRABVEGLYDG-UHFFFAOYSA-N
Pubchem ID :2466

Safety of Bufexamac

Related Pathways of Bufexamac

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HL60 cells 33.99 µM 72 hours Test the antiproliferative effects of Bufexamac and its derivatives on HL60 cells, showing a GI50 value of 33.99 µM for Bufexamac. Molecules. 2018 Feb 2;23(2):321.
Neutrophils 12.91 ± 4.02 μM (IC50) 30 minutes Bufexamac significantly inhibited the release of LTB4 in neutrophils with an IC50 of 12.91 ± 4.02 μM. Sci Rep. 2016 Apr 29;6:25298.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice LPS-induced acute lung injury model Oral 50 mg/kg and 100 mg/kg Once daily for 7 days Bufexamac significantly ameliorated LPS-induced lung histopathologic changes, reduced lung edema and permeability, decreased total cell numbers and protein levels in BALF, inhibited neutrophil infiltration and LTB4 levels, and down-regulated pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) expression. Sci Rep. 2016 Apr 29;6:25298.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.48mL

0.90mL

0.45mL

22.39mL

4.48mL

2.24mL

44.79mL

8.96mL

4.48mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories